Foresite Capital Management IV, LLC Diversified Active

Name: Foresite Capital Management IV, LLC Q3 2020 13F Filing | 13F Explorer
Creator: Foresite Capital Management IV, LLC
Published: 2020-11-13

Location: West Hollywood, CA

CIK: 0001704132 · Show all filings

Period: Q3 2020 (← Previous) (Next →)

Filing Date: Nov 13, 2020

Total Value: $443M (100.0% shares, 0.0% debt)

Holdings (15)

RLAY Relay Therapeutics, Inc. 20.5%

Value $91.12M Shares 2,139,380 Est. Cost $38.13 Unrealized 0.0%

NRIX Nurix Therapeutics, Inc. 18.5%

Value $81.97M Shares 2,348,014 Est. Cost $25.20 Unrealized 0.0%

KROS Keros Therapeutics, Inc. 12.3%

Value $54.49M Shares 1,412,705 Est. Cost $30.81 Unrealized +28.7%

KURA Kura Oncology, Inc. 9.0%

Value $40.08M Shares 1,307,982 Est. Cost $14.39 Unrealized +53.4%

ALXO ALX Oncology Holdings Inc. 8.3%

Value $36.74M Shares 973,514 Est. Cost $39.31 Unrealized 0.0%

CYTK Cytokinetics Incorporated 8.2%

Value $36.2M Shares 1,672,292 Est. Cost $8.72 Unrealized +168.2%

— Generation Bio Co. 6.0%

Value $26.52M Shares 857,939 Est. Cost $21.00 Unrealized —

PCVX Vaxcyte, Inc. 5.2%

Value $23M Shares 465,821 Est. Cost $32.16 Unrealized +23.8%

— Myokardia, Inc. 3.9%

Value $17.25M Shares 126,492 Est. Cost $47.61 Unrealized —

— Cymabay Therapeutics, Inc. 2.9%

Value $12.94M Shares 1,787,094 Est. Cost $3.49 Unrealized —

ABUS Arbutus Biopharma Corp 2.4%

Value $10.43M Shares 3,332,616 Est. Cost $3.04 Unrealized 0.0%

VYGR Voyager Therapeutics, Inc. 1.2%

Value $5.514M Shares 516,751 Est. Cost $21.95 Unrealized —

— Therapeutics Acquisition Corp 1.1%

Value $5.033M Shares 350,000 Est. Cost $14.38 Unrealized —

— Panacea Acquisition Corp 0.4%

Value $1.8M Shares 150,000 Est. Cost $12.00 Unrealized —

ACRS Aclaris Therapeutics, Inc. 0.1%

Value $372K Shares 144,874 Est. Cost $2.24 Unrealized 0.0%

Ticker	Issuer	Shares	Value	%	Est. Cost	Unrealized	Class	CUSIP
RLAY	Relay Therapeutics, Inc.	2,139,380	$91.12M	20.5%	$38.13	0.0%	COM	75943R102
NRIX	Nurix Therapeutics, Inc.	2,348,014	$81.97M	18.5%	$25.20	0.0%	COM	67080M103
KROS	Keros Therapeutics, Inc.	1,412,705	$54.49M	12.3%	$30.81	+28.7%	COM	492327101
KURA	Kura Oncology, Inc.	1,307,982	$40.08M	9.0%	$14.39	+53.4%	COM	50127T109
ALXO	ALX Oncology Holdings Inc.	973,514	$36.74M	8.3%	$39.31	0.0%	COM	00166B105
CYTK	Cytokinetics Incorporated	1,672,292	$36.2M	8.2%	$8.72	+168.2%	COM	23282W605
—	Generation Bio Co.	857,939	$26.52M	6.0%	$21.00	—	COM	37148K100
PCVX	Vaxcyte, Inc.	465,821	$23M	5.2%	$32.16	+23.8%	COM	92243G108
—	Myokardia, Inc.	126,492	$17.25M	3.9%	$47.61	—	COM	62857M105
—	Cymabay Therapeutics, Inc.	1,787,094	$12.94M	2.9%	$3.49	—	COM	23257D103
ABUS	Arbutus Biopharma Corp	3,332,616	$10.43M	2.4%	$3.04	0.0%	COM	03879J100
VYGR	Voyager Therapeutics, Inc.	516,751	$5.514M	1.2%	$21.95	—	COM	92915B106
—	Therapeutics Acquisition Corp	350,000	$5.033M	1.1%	$14.38	—	COM CL A	88339T103
—	Panacea Acquisition Corp	150,000	$1.8M	0.4%	$12.00	—	UNIT	698102209
ACRS	Aclaris Therapeutics, Inc.	144,874	$372K	0.1%	$2.24	0.0%	COM	00461U105